From Detection to Decision-Making: Navigating Disease Progression and Treatment in Geographic Atrophy
July 17 | 4:00 PM EST
In-person
Moderated by Deepak Sambhara, MD, FASRS
Objectives:
- Examine the critical role of early detection in geographic atrophy (GA) to enable timely intervention and reduce the risk of irreversible vision loss.
- Discuss the role of complement inhibition as a therapeutic class for geographic atrophy, including considerations for patient selection and treatment timing.
- Apply real-world case examples to inform clinical decision-making, highlighting when and how GA therapies may be integrated into patient care.
To attend, physicians must be practicing ophthalmologists in the US actively treating patients with retinal diseases such as neovascular AMD, DME, or RVO.
This discussion is in-person only; there is no virtual option.
MEETING DETAILS
DATE & TIME
Friday, July 17, 2026
4:00 PM - 6:00 PM EST
Location
Moishes
1001, rue du Square Victoria
Montreal, Canada
This discussion is held in-person only.
Join Ophthalmology Times® for a collaborative, small-group meeting designed around case-based clinical profiles and peer-dialogue led by an expert physician. This session offers practicing ophthalmologists the perfect opportunity to sharpen their skills and expertise in treatment strategies.
MARKET RESEARCH PARTICIPATION
Post-meeting, an Ophthalmology Times® survey will be provided to better understand physicians’ educational needs. For your contributions to the meeting and your completion of the short survey, Ophthalmology Times® is offering a compensation of $500.
Participation in the survey is mandatory.
Ophthalmology Times® — an MJH Life Sciences Brand
Copyright 2025 © All Rights Reserved.